StockData
Waters Corp logo

Waters Corp

WATNYSELaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30441% above fair value
$440.45−16.03 (-3.51%)

Close on Nov 20, 2026Market cap $43.27BP/E 109.8Yield –

Waters WBD — Flow Cytometry Research Solutions Revenue by Quarter

WBD — Flow Cytometry Research Solutions Revenue ($M)

Waters WBD — Flow Cytometry Research Solutions Revenue: $214M in Q3 2026, up 0.9% from a year earlier.

Latest, Q3 2026
214
Period ended Sep 30, 2026
Change on a year earlier
+0.9%
212 in Q3 2025
History
6 quarters
Since Q1 2025
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“Q3 2026 - Reconciliation Prior Year Comparable Revenue Growth (in millions USD): Biosciences: Flow Research 2026 214 vs 2025 212 (1%), Flow Clinical 2026 182 vs 2025 174 (4%), Total Biosciences - Q3 2026 396 vs 2025 387 (2%) | Advanced Diagnostics: Diagnostic Solutions 2026 500 vs 2025 498 (0%), Molecular Dx & Point of Care 2026 154 vs 2025 164 (-6%), Microbiology 2026 346 vs 2025 334 (4%), Clinical Business Unit 2026 75 vs 2025 64 (17%), Total Advanced Diagnostics - Q3 2026 ”

Source: Q3 2026 Earnings Presentation (2026-11-03), Slide 28 ↗

Reported in Q1-Q3 2026 Earnings Presentations (Reconciliation Appendix).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWBD — Flow Cytometry Research Solutions Revenue ($M)Year on yearSource
Q3 2026Sep 30, 2026214+0.9%Q3 2026 Earnings Presentation (2026-11-03), Slide 28 ↗
Q2 2026Jun 30, 2026198-1.5%Q2 2026 Earnings Presentation (2026-08-04), Slide 30 ↗
Q1 2026Mar 31, 2026131+7.4%Q1 2026 Earnings Presentation (2026-05-05), Slides 18 & 25-27 ↗
Q3 2025Sep 30, 2025212–Q3 2026 Earnings Presentation (2026-11-03), Slide 28 ↗
Q2 2025Jun 30, 2025201–Q2 2026 Earnings Presentation (2026-08-04), Slide 30 ↗
Q1 2025Mar 31, 2025122–Q1 2026 Earnings Presentation (2026-05-05), Slides 18 & 25-27 ↗

Breakdown

What makes up WBD — Flow Cytometry Research Solutions Revenue

Cite this data

StockData. (2026). Waters WBD — Flow Cytometry Research Solutions Revenue ($M), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Waters SEC filings and investor materials. https://stockdatahq.com/stocks/wat/kpis/wbd-flow-research

See every metric in the Waters KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?